Study of Glycopyrronium in Axillary Hyperhydrosis
Public ClinicalTrials.gov record NCT02530281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Glycopyrronium in Subjects With Axillary Hyperhydrosis
Study identification
- NCT ID
- NCT02530281
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Journey Medical Corporation
- Industry
- Enrollment
- 344 participants
Conditions and interventions
Conditions
Interventions
- glycopyrronium Topical Wipes Drug
- Vehicle Other
Drug · Other
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2015
- Primary completion
- Feb 29, 2016
- Completion
- Feb 29, 2016
- Last update posted
- Aug 24, 2021
2015 – 2016
United States locations
- U.S. sites
- 21
- U.S. states
- 11
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research, Inc. | Mobile | Alabama | 36608 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| Therapeutics Clinical Research | San Diego | California | 92123 | — |
| Skin Care Research, Inc. | Boca Raton | Florida | 33486 | — |
| Study Protocol, Inc. | Boynton Beach | Florida | 33437 | — |
| International Dermatology Research, Inc. | Miami | Florida | 33144 | — |
| Tory Sullivan, M.D., P.A. | North Miami Beach | Florida | 33162 | — |
| Research Institute of the Southeast | West Palm Beach | Florida | 33401 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Prairie Health and Wellness | Wichita | Kansas | 67226 | — |
| St. Louis University Dermatology | St Louis | Missouri | 63122 | — |
| Meridian Clinical Research | Omaha | Nebraska | 68134 | — |
| Dermatology and Laser Center | Charleston | South Carolina | 29414 | — |
| Rivergate Dermatology Clinical Research Center, PLLC | Goodlettsville | Tennessee | 37072 | — |
| DermResearch | Austin | Texas | 78759 | — |
| J&S Studies | College Station | Texas | 77845 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78860 | — |
| ACRC Trials / Innovative Dermatology | Plano | Texas | 75024 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Charlottesville Dermatology Research Center | Charlottesville | Virginia | 22911 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02530281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02530281 live on ClinicalTrials.gov.